| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Barriers and strategies to achieve a cure for HIV MC Pitman, JSY Lau, JH McMahon, SR Lewin The Lancet HIV 5 (6), e317-e328, 2018 | 118 | 2018 |
| Clinical trials of antiretroviral treatment interruption in HIV-infected individuals JSY Lau, MZ Smith, SR Lewin, JH McMahon Aids 33 (5), 773-791, 2019 | 49 | 2019 |
| Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis? YD Lin, SE Garner, JSY Lau, TM Korman, IJ Woolley QJM: An International Journal of Medicine 112 (1), 17-21, 2019 | 31 | 2019 |
| Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial JH McMahon, JSY Lau, A Coldham, J Roney, M Hagenauer, S Price, ... EClinicalMedicine 54, 2022 | 30 | 2022 |
| Life-long antimicrobial therapy: where is the evidence? JSY Lau, TM Korman, I Woolley Journal of Antimicrobial Chemotherapy 73 (10), 2601-2612, 2018 | 29 | 2018 |
| Perspectives on analytical treatment interruptions in people living with HIV and their health care providers in the landscape of HIV cure-focused studies JSY Lau, MZ Smith, B Allan, C Martinez, J Power, SR Lewin, JH McMahon AIDS research and human retroviruses 36 (4), 260-267, 2020 | 28 | 2020 |
| Epstein-Barr virus encephalitis in solid organ transplantation JSY Lau, ZM Low, I Abbott, L Shochet, J Kanellis, AR Kitching, ... New Microbiol 40 (3), 212-217, 2017 | 27 | 2017 |
| The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy JSY Lau, JH McMahon, C Gubser, A Solomon, CYH Chiu, ... Aids 35 (10), 1631-1636, 2021 | 22 | 2021 |
| The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia M Weerasuria, C Ko, A Ehm, J O'Bryan, J McMahon, I Woolley, J Hoy, ... AIDS research and human retroviruses 37 (4), 322-328, 2021 | 22 | 2021 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of multidrug and extensively drug-resistant tuberculosis: a multicentre study SE Borisov, K Dheda, M Enwerem, R Romero Leyet, L D’Ambrosio, ... Eur Respir J 49 (5), 1700387, 2017 | 22 | 2017 |
| Bacteroides pyogenes causing serious human wound infection from animal bites JSY Lau, TM Korman, A Yeung, R Streitberg, MJ Francis, M Graham Anaerobe 42, 172-175, 2016 | 21 | 2016 |
| Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network JSY Lau, C Kiss, E Roberts, K Horne, TM Korman, I Woolley Annals of clinical microbiology and antimicrobials 16, 1-4, 2017 | 19 | 2017 |
| A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls JH McMahon, JM Zerbato, JSY Lau, JL Lange, M Roche, C Tumpach, ... EBioMedicine 65, 2021 | 16 | 2021 |
| Myocarditis caused by human parechovirus in adult KL Kong, JSY Lau, SM Goh, HL Wilson, M Catton, TM Korman Emerging Infectious Diseases 23 (9), 1571, 2017 | 16 | 2017 |
| Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency TA Rasmussen, JM Zerbato, A Rhodes, C Tumpach, A Dantanarayana, ... Cell Reports Medicine 3 (10), 2022 | 13 | 2022 |
| Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies JSY Lau, MZ Smith, B Allan, C Martinez, J Power, SR Lewin, JH McMahon AIDS Research and Therapy 17, 1-6, 2020 | 12 | 2020 |
| Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science JSY Lau, MZ Smith, B Allan, K Dubé, AT Young, J Power Journal of Virus Eradication 6 (4), 100018, 2020 | 12 | 2020 |
| Human wound infection with Mannheimia glucosida following lamb bite JSY Lau, L Omaleki, C Turni, SR Barber, GF Browning, MJ Francis, ... Journal of Clinical Microbiology 53 (10), 3374-3376, 2015 | 10 | 2015 |
| Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial JD Gunst, JF Højen, MH Pahus, M Rosás-Umbert, B Stiksrud, ... Nature Medicine 29 (10), 2547-2558, 2023 | 9 | 2023 |
